Comment
doi: 10.1253/circj.cj-14-0890.
Epub 2014 Sep 16.
PRASFIT-ACS: important evidence against a "one-guideline-fits-all-races" approach to antiplatelet therapy
Affiliations
- PMID: 25225176
- DOI: 10.1253/circj.cj-14-0890
Item in Clipboard
Comment
PRASFIT-ACS: important evidence against a "one-guideline-fits-all-races" approach to antiplatelet therapy
Circ J.
2014.
No abstract available
Comment on
-
Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study.Circ J. 2014;78(7):1684-92. doi: 10.1253/circj.cj-13-1482. Epub 2014 Apr 22. Circ J. 2014. PMID: 24759796 Clinical Trial.
-
PRASFIT-ACS: important evidence against a "one-guideline-fits-all-races" approach to antiplatelet therapy.Circ J. 2014;78(10):2563. doi: 10.1253/circj.cj-14-0663. Epub 2014 Sep 16. Circ J. 2014. PMID: 25225175 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical